STAAR Surgical Stock Forecast, Price & News

STAAR Surgical (NASDAQ:STAA) Frequently Asked Questions

Is STAAR Surgical a buy right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for STAAR Surgical in the last year. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" STAAR Surgical stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in STAA, but not buy additional shares or sell existing shares.
View analyst ratings for STAAR Surgical or view top-rated stocks.

How has STAAR Surgical's stock been impacted by Coronavirus?

STAAR Surgical's stock was trading at $28.01 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, STAA shares have increased by 246.9% and is now trading at $97.18.
View which stocks have been most impacted by COVID-19.

When is STAAR Surgical's next earnings date?

STAAR Surgical is scheduled to release its next quarterly earnings announcement on Wednesday, February 23rd 2022.
View our earnings forecast for STAAR Surgical.

How were STAAR Surgical's earnings last quarter?

STAAR Surgical (NASDAQ:STAA) posted its earnings results on Wednesday, November, 3rd. The medical instruments supplier reported $0.12 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.11 by $0.01. The medical instruments supplier earned $58.35 million during the quarter, compared to analysts' expectations of $57.70 million. STAAR Surgical had a net margin of 10.53% and a trailing twelve-month return on equity of 13.06%. During the same period in the previous year, the company earned $0.14 earnings per share.
View STAAR Surgical's earnings history.

What guidance has STAAR Surgical issued on next quarter's earnings?

STAAR Surgical updated its FY 2021 earnings guidance on Wednesday, November, 17th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $230 million-$231 million, compared to the consensus revenue estimate of $229.17 million.

What price target have analysts set for STAA?

4 equities research analysts have issued 1-year target prices for STAAR Surgical's shares. Their forecasts range from $150.00 to $150.00. On average, they anticipate STAAR Surgical's share price to reach $150.00 in the next year. This suggests a possible upside of 54.4% from the stock's current price.
View analysts' price targets for STAAR Surgical or view top-rated stocks among Wall Street analysts.

Who are STAAR Surgical's key executives?

STAAR Surgical's management team includes the following people:

• Caren L. Mason, President, Chief Executive Officer & Director (LinkedIn Profile)
• Graydon Hansen, Chief Manufacturing Officer & SVP-Global Operation (LinkedIn Profile)
• Patrick F. Williams, Chief Financial Officer & Vice President (LinkedIn Profile)
• Keith Holliday, Chief Technology Officer
• Scott D. Barnes, Chief Medical Officer

What is Caren Mason's approval rating as STAAR Surgical's CEO?

6 employees have rated STAAR Surgical CEO Caren Mason on Glassdoor.com. Caren Mason has an approval rating of 68% among STAAR Surgical's employees.

Who are some of STAAR Surgical's key competitors?

Some companies that are related to STAAR Surgical include Align Technology (ALGN), West Pharmaceutical Services (WST), Cooper Companies (COO), DENTSPLY SIRONA (XRAY), Quidel (QDEL), ICU Medical (ICUI), Neogen (NEOG), Merit Medical Systems (MMSI), Haemonetics (HAE), Atrion (ATRI), Cerus (CERS), Meridian Bioscience (VIVO), OraSure Technologies (OSUR), Anika Therapeutics (ANIK) and Antares Pharma (ATRS).
View all of STAA's competitors.

What other stocks do shareholders of STAAR Surgical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STAAR Surgical investors own include Tesla (TSLA), NVIDIA (NVDA), PayPal (PYPL), Walt Disney (DIS), CrowdStrike (CRWD), DocuSign (DOCU), Shopify (SHOP), Trade Desk (TTD), Teladoc Health (TDOC) and Roku (ROKU).

What is STAAR Surgical's stock symbol?

STAAR Surgical trades on the NASDAQ under the ticker symbol "STAA."

Who are STAAR Surgical's major shareholders?

STAAR Surgical's stock is owned by many different retail and institutional investors. Top institutional investors include Broadwood Capital Inc. (18.20%), BlackRock Inc. (11.62%), Baillie Gifford & Co. (11.53%), Ensign Peak Advisors Inc (1.79%), Geode Capital Management LLC (1.74%) and Geneva Capital Management LLC (1.46%). Company insiders that own STAAR Surgical stock include Broadwood Partners, LP, Caren L Mason, Deborah J Andrews, Graydon C Hansen, Hans-Martin Blickensdoerfer, James E Francese, Jon K Hayashida, Keith Holliday, Patrick F Williams and Samuel J Gesten.
View institutional ownership trends for STAAR Surgical.

Which major investors are selling STAAR Surgical stock?

STAA stock was sold by a variety of institutional investors in the last quarter, including Invesco Ltd., Morgan Stanley, Geneva Capital Management LLC, Baillie Gifford & Co., Goldman Sachs Group Inc., TCW Group Inc., Millennium Management LLC, and RE Advisers Corp. Company insiders that have sold STAAR Surgical company stock in the last year include Broadwood Partners, LP, Caren L Mason, Graydon C Hansen, Hans-Martin Blickensdoerfer, James E Francese, Jon K Hayashida, Keith Holliday, Patrick F Williams, and Samuel J Gesten.
View insider buying and selling activity for STAAR Surgical or view top insider-selling stocks.

Which major investors are buying STAAR Surgical stock?

STAA stock was purchased by a variety of institutional investors in the last quarter, including Kayne Anderson Rudnick Investment Management LLC, Pura Vida Investments LLC, E Fund Management Co. Ltd., Aegon Asset Management UK PLC, Citigroup Inc., Dimensional Fund Advisors LP, BlackRock Inc., and Two Sigma Advisers LP.
View insider buying and selling activity for STAAR Surgical or or view top insider-buying stocks.

How do I buy shares of STAAR Surgical?

Shares of STAA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is STAAR Surgical's stock price today?

One share of STAA stock can currently be purchased for approximately $97.18.

How much money does STAAR Surgical make?

STAAR Surgical has a market capitalization of $4.63 billion and generates $163.46 million in revenue each year. The medical instruments supplier earns $5.91 million in net income (profit) each year or $0.46 on an earnings per share basis.

How many employees does STAAR Surgical have?

STAAR Surgical employs 575 workers across the globe.

Does STAAR Surgical have any subsidiaries?

The following companies are subsidiares of STAAR Surgical: Canon Staar, Frigitronics Inc., STAAR Japan Inc., STAAR Optical Equipment, STAAR Surgical AG, STAAR Surgical PTE. LTD, and Technology (Shanghai) Co. LTD.

When was STAAR Surgical founded?

STAAR Surgical was founded in 1982.

What is STAAR Surgical's official website?

The official website for STAAR Surgical is www.staar.com.

Where are STAAR Surgical's headquarters?

STAAR Surgical is headquartered at 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630.

How can I contact STAAR Surgical?

STAAR Surgical's mailing address is 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630. The medical instruments supplier can be reached via phone at (626) 303-7902, via email at [email protected], or via fax at 626-303-2962.